0
Rishi Sunak was subjected to a man’s furious rant over the Covid vaccine during a live forum on GB News on Monday (13 February). John Watt, gestured towards the prime minister as he claimed he was among 30,000 that had suffered side effects as a re ...
0
This vivid account of the Hungarian biochemist who endured decades of derision before pioneering Pfizer’s Covid vaccine is a tribute to her tenacity and self-belief
0
The arrest affidavit said the man had also started consuming cocaine
0
The country has one of the world’s highest death rates from the disease but a campaign led by young mothers is ensuring girls have access to the HPV vaccine
0
Two decades of work in the field of cancer vaccines finally starting to bear fruit, experts say
0
New data from a phase 3 trial of R21/Matrix-M in African children confirmed the jab is effective and safe.
0
MSF begins vaccine drive against incurable disease, which is spread via dirty water and kills thousands of pregnant women
0
The treatment will trialled at the Royal Surrey NHS Foundation Trust and Queen Elizabeth Hospital in Adelaide.
0
Dr Clive Dix says all activities to prepare for next outbreak are ‘literally gone’ and vaccine manufacturers have been driven away
0
Professor Sir Andrew Pollard’s team created the Oxford/AstraZeneca Covid-19 jab during the pandemic.
0
Students affected by the scheme will be forced to get up-to-date vaccinations before they are allowed back in school
0
Another 19 African countries have plans to join the programme – bringing ‘more than just hope’ to a continent that suffers the vast majority of malaria deaths
0
Health experts hope about 6.6 million children will be given jabs this year and next across 20 African countries
0
Researchers at LSHTM have been working alongside local communities in Africa for almost three decades to research, develop and deploy the jab.
0
Darius Hughes was a key figure in Pfizer’s pioneering Covid vaccine drive. Now he has changed companies – and sees a big future for mRNA technology
0
Resurgence classified as grade 3 emergency by WHO, with southern Africa and Haiti among those hardest hit
0
‘These vaccines are not appropriate for use in human beings,’ Dr Ladapo wrote
0
International research indicates giving infants nirsevimab would cause sharp drop in rates of respiratory syncytial virus infection
0
Research by a team led by Sean O’Leary, MD, shows that parental vaccine hesitancy remained unchanged during COVID-19, but trust levels vacillated.
0
Britain’s biggest drugmaker acquires Seattle-based firm Icosavax, expanding vaccine and immune therapy business